THE BRITISH URO-ONCOLOGY GROUP

Registered charity 1116828 · accounts filings on the Charity Commission register · also known as BUG

Annual educational meeting. Website with educational resources. Meetings reviewing service delivery for prostate cancer patients. Dissemination of information.

Causes: Education/training · website · Get email alerts

Latest income
£231k
Latest spending
£224k
Registered
2006
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that free reserves stood at £137,893, which the trustees consider sufficient to meet the charity's needs and equate to approximately six months of resources expended. Total incoming resources decreased to £230,900 from £296,886 in the prior year, while total expenditure also decreased to £223,830. The charity reported a net income of £7,070 for the period, resulting in a slight increase in unrestricted funds.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: six months of the resources expended (held: £138k)
The trustees consider that given the nature of the work of the charity and assuming that the charity's activities continue at the current levels, this should equate to approximately six months of the resources expended
Per its FY2024 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/12/2024£231k£224k
31/12/2023£297k£342k
31/12/2022£277k£248k
31/12/2021£247k£222k
31/12/2020£162k£248k

Common questions

Is THE BRITISH URO-ONCOLOGY GROUP financially healthy?

Per its FY2024 accounts: The accounts state that free reserves stood at £137,893, which the trustees consider sufficient to meet the charity's needs and equate to approximately six months of resources expended. Total incoming resources decreased to £230,900 from £296,886 in the prior year, while total expenditure also decreased to £223,830. The charity reported a net income of £7,070 for the period, resulting in a slight increase in unrestricted funds. Its FY2024 accounts were independently examined.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with THE CANCER TREATMENT AND RESEARCH TRUST CIO.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
THE BRITISH URO-ONCOLOGY GROUP£231k0unclearno doubt
THE CANCER TREATMENT AND RESEARCH TRUST CIO FY2024£502k0aboveno doubt
COLCHESTER HAS ACTIVE PROSTATE SUPPORT FY2025£200k0unclearno doubt
ROYAL GLAMORGAN POSTGRADUATE MEDICAL CENTRE ASSOCIATION FY2025£114k0unclearno doubt
ACADEMY OF MEDICAL SCIENCES FY2025£27.0maboveno doubt
YAD VEACHISOMOCH L'CHAIM FY2025£834k0unclearno doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.